Upload
damita
View
51
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Fibrinogen Adsorption on Antimicrobial Modified Surfaces. Julie Auxier Dr. Joseph McGuire, Bioengineering Oregon State University HHMI 2009. Imperfect Implants. Problems from implanted devices: Clotting; embolism risk Bacterial adhesion; infection Overall implant rejection - PowerPoint PPT Presentation
Citation preview
Julie AuxierDr. Joseph McGuire, Bioengineering
Oregon State UniversityHHMI 2009
Imperfect ImplantsProblems from implanted
devices:Clotting; embolism riskBacterial adhesion; infectionOverall implant rejection
Treat with heparin and other anticoagulantsRisk of platelet depletion,
excessive bleeding
Thrombosis and Blood Proteins Thrombosis: formation of a blood clot in a blood
vessel which obstructs blood flow
Intrinsic Pathway
Extrinsic Pathway
Tissue Damage
Tissue Factor
III
Factor VII Tissue Factor
Complex
Clotting Factor VII
Activated Proenzymes, usually Factor XIII
Platelet Factor PF-3
Clotting Factors VIII,
IX
Factor X Activator Complex
Ca2+
Ca2+
Fibrinogen
Fibrin
Prothrombin Thrombin
Factor X
Prothrombinase
Common Pathway
Thrombosis and Blood ProteinsFibrin forms the
scaffolding, platelets fill the holes
Late stent thrombosis possibly caused by: Early discontinuation of
anticoagulant medication Stent fracture Abnormal reaction of tissue to
implant material Small lumen size, slow flow rate
Prevention with Pluronic® F108
HYDROPHOBIC
HYDROPHILICPEO
PEO
PPO
HYDROPHOBIC SURFACE
F108 approximate maximum length: 50nm
Approximate length of a red blood cell: 5µm
(500nm)
HYDROPHOBIC
PROTEI
N
How Brush Layer Functions
Nisin - Lantibiotic Inactivate bacteria by creating a pore and destabilizing the membrane Naturally made from bacteria Lactococcus lactisUsed in food products: preservative, making cheeseNo evidence suggests nisin induces an immunogenic reaction (based
on previous studies)
Hydrophobic Surface
Previous ResearchChange between pluronic coating with nisin before and
after challenged with fibrinogen.
Two possibilities may account for the lower signal
PurposeIdentify fibrinogen adsorption on non-
fouling, antimicrobial surfaces.
HypothesisThe pluronic layer maintains its protein
repelling nature despite nisin loading. Hence, fibrinogen more likely will not adsorb to the
surface and will displace nisin when repelled.
MethodologySurface preparation:
Silanize silica to make surface hydrophobic
Covalently attach pluronic F108 by gamma radiation
Load brush layer with nisin
Protein assay tests (ELISA)
FITC labeling fibrinogen
Parallel flow platelet adhesion tests
Inactivated Platelets
Fibrinogen
Surface
Enzyme Linked Immunosorbant Assay
Surface
Fibrinogen sticks to sample surface.
Add enzyme-linked antibody which attaches to fibrinogen.
Add colorimetric substrate to react with enzyme on antibody.
Solution changes color, read absorbance at 490nm.
Block well with bovine serum albumin (BSA) or milk.“Tagged” fibrinogen
antibody detects fibrinogen in a sample, and then a colorimetric substrate detects the antibody
Results
*Not to scale.
FITC labeling fibrinogen Fluoroscein isothiocyanate reacts with N-
terminal amines on fibrinogen.
Prepare labeled fibrinogen solution.
Contact surfaces (microspheres) with labeled fibrinogen.
Rinse thoroughly.
Dissolve microspheres with NaOH.
Read absorbance at 490nm.
Results
Parallel Flow Platelet Adhesion Flow chamber allows for evenly distributed flow at a constant rate (16 mL/min,
shear rate 480 sec-1)
Flow platelet-rich equine plasma through system.
Buffer wash.
Fix platelets with gluteraldehyde.
Buffer wash.
Dehydrate with ethanol.
Critical point dry.
Image with SEM.
Results
ConclusionsELISA and FITC-Fg results indicate:
Brush layer effectively inhibits fibrinogen adsorption.
Addition of nisin to the brush layer does not promote fibrinogen adsorption.
Platelet adhesion studies require refining before definitive results may be collected.
Future WorkContinue work with parallel flow chamber.
Repeat FITC-Fg tests.
Investigate labeling fibrinogen with trifluoroacetic anhydride which can be quantified using x-ray photon spectroscopy (XPS).
AcknowledgementsGreat deal of thanks to:Dr. Joe McGuireKarl “Rat” SchilkeDr. Karyn BirdMatt RyderLars BowlinHoward Hughes Medical InstituteAllvivo Vascular Inc.